acute disseminated encephalomyelitis: An encephalomyelitis characterized by inflammation located_in brain and located_in spinal cord that damages myelin. It usually occurs after viral infection, but also following vaccination, bacterial or parasitic infection.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
66 |
4. Check minimum number of eventsNone |
66 |
5. Include endpointsNone |
66 |
6. Filter based on genotype QC (FinnGen only) |
66 |
Control definitions (FinnGen only)
- Control exclude
- G6_NEUINFL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G04
- Name in latin
- Encephalitis disseminata acuta
Similar endpoints
↥List of similar endpoints to
Acute disseminated encephalitis/encephalomyelitis
based on the number of shared cases.
Similar with more cases:
- Encephalitis
- Inflammatory diseases of the central nervous system
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 676 | 304 | 364 |
| Only index persons | 537 | 257 | 280 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 21.71 | 24.51 | 18.75 |
| Only index persons | 20.47 | 23.38 | 17.79 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 66 | 40 | 26 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 25.74 | 24.83 | 27.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 58
- Matched controls
- 578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
32300
ICD-8 Finland
Encephalitis, myelitis and encephalomyelitis, Encephalitis postinfectiosa
+∞
36.3
31
*
G04.0
ICD-10 Finland
Acute disseminated encephalitis
+∞
31.0
27
*
TAB00
NOMESCO Finland
Lumbar puncture
25.7
10.4
14
7
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
+∞
9.6
9
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
19.0
7.6
11
7
G40.9
ICD-10 Finland
Epilepsy, unspecified
19.7
7.0
10
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016018) Differential panel - Cerebral spinal fluid
7
5
15.41
4.68
1.3
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
14
7.25
4.14
1.7
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
5
13.00
3.84
1.3
1.0
—
—
—
0
0
(4027681)
6
5
13.00
3.84
1.7
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
9
8.53
3.65
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
11
6.96
3.27
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
12
6.38
3.11
1.0
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
28
176
2.03
2.00
5.6
6.1
inr
1.0
1.1
—
8
57
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
176
2.03
2.00
5.8
3.4
ng/l
20.2
25.3
0.24
18
113
(3018418) pH of Serum or Plasma
23
136
2.06
1.92
3.4
3.9
ph
7.4
7.4
—
6
29
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
12
4.41
1.86
1.0
1.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
30
2.89
1.79
8.1
3.9
mmol/l
25.8
24.7
—
8
30
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
18
3.56
1.79
1.8
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
19
3.36
1.70
1.2
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
20
3.19
1.62
1.7
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
28
2.67
1.50
1.6
2.5
—
—
—
0
0
(3019225) pH of Specimen
9
40
2.44
1.47
4.9
5.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
16
3.29
1.46
6.2
1.9
g/l
3.2
3.8
—
5
16
(42870588) Differential panel, method unspecified - Blood
25
167
1.80
1.41
8.3
6.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
23
2.76
1.40
4.8
1.7
%
88.5
93.9
—
6
23
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
70
2.07
1.35
2.1
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
24
160
1.79
1.35
2.9
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
35
2.46
1.32
1.8
6.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
27
188
1.74
1.31
4.8
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
18
2.92
1.31
8.2
5.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
18
2.92
1.31
3.6
36.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
22
145
1.78
1.28
5.1
2.4
u/l
220.3
245.6
0.06
22
138
(3023368) Bacteria identified in Blood by Culture
18
112
1.83
1.25
4.4
5.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
45
364
1.74
1.25
4.9
4.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
12
66
2.00
1.18
3.4
2.1
s
28.8
28.5
0.13
12
66
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
20
2.62
1.17
1.2
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
34
260
1.63
1.13
8.5
6.9
e9/l
1.9
1.9
0.18
29
235
(36304419) Bacteria [Presence] in Urine
22
150
1.70
1.12
4.4
2.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
35
272
1.61
1.07
4.0
3.4
estimate
0.0
0.0
—
10
48
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
17
109
1.75
1.07
2.8
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
22
2.37
1.05
1.2
1.5
—
326.7
—
0
12
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
5
22
2.37
1.05
1.4
1.9
ug/l
0.2
12.1
—
5
22
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
22
2.37
1.05
1.6
1.3
g/l
0.2
0.2
—
5
22
(3001604) Monocytes [#/volume] in Blood
33
256
1.58
1.00
8.6
6.9
e9/l
0.6
0.6
0.28
28
228
(3006315) Basophils [#/volume] in Blood
33
256
1.58
1.00
8.6
6.9
e9/l
0.0
0.0
0.12
28
228
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
51
1.88
0.99
1.7
1.6
—
—
—
0
0
(3015736) pH of Urine
29
219
1.58
0.98
2.9
3.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
27
201
1.58
0.97
4.4
3.3
e6/l
15.1
15.1
0.00
20
135
(3021601) Nitrite [Presence] in Urine by Test strip
34
271
1.53
0.88
5.5
4.7
estimate
0.0
0.0
—
10
49
(3035350) Ketones [Presence] in Urine by Test strip
34
271
1.53
0.88
4.0
3.4
estimate
0.0
0.0
—
10
48
(3021589) Normoblasts [#/volume] in Blood
30
234
1.52
0.85
11.2
10.3
e9/l
0.0
0.0
0.00
25
190
(3019150) Specific gravity of Urine by Refractometry
17
116
1.63
0.85
3.5
3.5
kg/l
1.0
1.0
—
8
16
(3004789) Transferrin [Mass/volume] in Serum or Plasma
10
58
1.85
0.85
2.4
2.1
g/l
2.7
2.5
—
10
52
(3022948) Iron [Moles/volume] in Serum or Plasma
11
67
1.77
0.81
2.5
2.0
umol/l
13.3
14.9
0.24
11
62
(3008898) HLA-B27 [Presence]
0
24
0.00
0.81
0.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
26
0.00
0.80
0.0
2.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
23
2.27
0.78
1.6
1.3
g/l
1.1
1.2
—
5
23
(3014007) Fractional oxyhemoglobin in Arterial blood
5
23
2.27
0.78
1.4
8.5
%
93.7
92.6
—
5
23
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9
55
1.74
0.77
3.8
2.0
nmol/l
228.3
380.1
—
9
49
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
9
55
1.74
0.77
2.7
2.1
%
19.6
26.2
—
9
48
(3044889) 12 lead EKG panel
40
336
1.48
0.77
4.3
3.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
23
173
1.51
0.76
2.0
1.8
pmol/l
108.3
102.3
0.18
14
79
(3041096) Erythrocytes [Presence] in Urine by Automated
21
155
1.52
0.76
4.6
3.1
—
—
—
0
0
(3013512) EKG study
21
157
1.50
0.71
4.5
3.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
27
1.92
0.70
3.6
21.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
16
113
1.55
0.69
2.3
1.8
mg/l
1.5
0.9
0.41
11
90
(3026008) Bacteria identified in Urine by Culture
20
149
1.49
0.69
4.1
2.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
12
79
1.63
0.68
1.5
1.7
pmol/l
409.1
525.7
0.87
12
68
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
29
1.78
0.65
2.2
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
50
1.68
0.64
1.8
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
26
207
1.42
0.63
4.4
3.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
61
1.55
0.57
1.4
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
67
1.58
0.53
1.5
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
40
1.55
0.53
1.7
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
15
111
1.45
0.52
3.8
2.6
mmol/l
6.0
7.7
1.40
15
91
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
120
1.44
0.52
1.3
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
7
45
1.62
0.51
7.0
3.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
57
535
1.48
0.49
18.2
13.9
mmol/l
3.9
4.0
0.63
57
518
(3007164) IgA [Mass/volume] in Serum or Plasma
16
123
1.40
0.46
2.0
1.3
g/l
2.6
2.2
0.34
11
69
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
123
1.40
0.46
2.4
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
45
408
1.32
0.42
7.5
7.7
u/l
73.7
78.6
0.47
40
382
(3039443) Prostate specific Ag panel - Serum or Plasma
0
15
0.00
0.42
0.0
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
15
0.00
0.42
0.0
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
35
308
1.29
0.41
8.1
12.0
e9/l
4.5
3.9
0.76
30
272
(4034850)
0
18
0.00
0.40
0.0
11.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
23
192
1.30
0.39
2.6
3.1
u/l
34.3
28.6
0.77
23
180
(3042936) Bacteria identified in Isolate by Culture
9
69
1.35
0.39
4.0
2.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
6
41
1.51
0.37
1.5
7.2
mmol/l
106.7
103.6
—
6
41
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
73
1.44
0.37
1.4
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
17
138
1.31
0.35
5.2
3.5
estimate
0.0
0.0
—
10
49
(3000492) Spirometry study
6
46
1.33
0.34
1.5
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
45
415
1.27
0.33
3.2
3.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
56
531
1.36
0.32
18.7
14.0
mmol/l
139.2
139.8
0.86
56
514
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
104
1.31
0.29
1.4
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
11
88
1.30
0.24
4.1
2.5
e6/l
0.6
0.7
—
6
48
(4035726)
5
38
1.34
0.24
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
5
38
1.34
0.24
4.6
3.3
g/l
0.2
0.2
—
5
38
(3025941) Bacteria identified in Stool by Culture
5
39
1.30
0.23
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
41
1.24
0.22
3.0
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
28
253
1.19
0.22
3.8
4.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
15
127
1.23
0.22
7.9
6.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
10
80
1.29
0.22
4.4
2.6
e6/l
1.0
2.6
—
5
41
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
65.1
—
0
12
(3014051) Protein [Presence] in Urine by Test strip
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
60
613
0.77
0.21
25.1
18.6
fl
90.2
90.5
0.15
60
603
(3012544) pH of Venous blood
6
47
1.30
0.21
2.3
3.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
60
613
0.77
0.21
25.0
18.6
pg
30.0
30.2
0.48
60
603
(3000963) Hemoglobin [Mass/volume] in Blood
60
613
0.77
0.21
25.5
18.8
g/l
135.6
137.3
0.45
60
603
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
4.5
—
11.3
—
0
13
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
0.1
—
0
6
(40768804) Tissue Pathology biopsy report
23
206
1.18
0.19
2.6
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
82
1.26
0.18
3.0
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
68
1.20
0.17
2.9
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
8
68
1.20
0.17
1.5
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
15
131
1.19
0.16
7.1
8.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
57
579
0.89
0.16
16.7
11.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
104
1.19
0.13
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
24
222
1.13
0.12
2.2
2.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
45
1.12
0.10
1.6
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
47
1.07
0.09
1.2
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
53
516
1.14
0.09
14.5
12.9
%
41.6
40.8
0.66
38
409
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
54
1.12
0.09
10.2
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
56
547
1.16
0.09
19.4
13.1
mg/l
18.2
20.0
0.23
49
405
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
58
1.04
0.08
3.7
6.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
6
58
1.04
0.08
6.0
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
14
127
1.13
0.08
2.9
3.2
—
—
—
0
0
(3002256) Pathology report gross observation
7
68
1.03
0.08
1.6
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
75
1.08
0.08
3.1
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
76
1.06
0.08
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
48
470
1.08
0.04
17.6
15.4
%
13.4
13.5
0.32
48
459
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
14
133
1.07
0.02
2.4
2.9
ng/l
845.3
895.4
—
9
109
(3003694) ABO and Rh group [Type] in Blood
18
174
1.05
0.00
1.7
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
28
275
1.03
0.00
5.9
7.1
umol/l
8.1
10.1
1.51
23
262
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
11.2
—
0.7
—
0
5
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
4.2
—
33.0
—
0
5
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
57.6
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
137.0
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
1.4
—
12.8
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
108.2
—
0
5
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
23.8
—
0
6
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
11.0
—
1235.5
—
0
6
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
6
0.00
0.00
0.0
8.8
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
7.7
—
180.3
—
0
6
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.2
—
765.8
—
0
6
(3023419) Bacteria identified in Sputum by Culture
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
54
0.92
0.00
1.8
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
3.0
—
0
8
(3000494) Fungus identified in Specimen by Culture
6
65
0.92
0.00
1.7
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_ADEM and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have G6_ADEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: G6_ADEM – Acute disseminated encephalitis/encephalomyelitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data